- ¥2980
- LMAI Bio
- LM-11337R-FITC
- 中国/美国/欧洲
- 2025年07月13日
- ICC=1:50-200 IF=1:50-200
- Human, Mouse, Rat, Dog, Horse, Rabbit,
- Human, Mouse, Rat, Dog, Horse, Rabbit,
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
上海联迈生物工程有限公司
- 库存：
大量
- 靶点：
详见说明书
- 级别：
1
- 目录编号：
LM-11337R-FITC
- 克隆性：
多克隆
- 抗原来源：
Rabbit
- 保质期：
1年
- 抗体英文名：
Anti-C1QC/FITC
- 抗体名：
Anti-C1QC/FITC
- 标记物：
FITC标记
- 宿主：
Human, Mouse, Rat, Dog, Horse, Rabbit,
- 适应物种：
Human, Mouse, Rat, Dog, Horse, Rabbit,
- 免疫原：
详见说明书
- 亚型：
IGg
- 形态：
粉末、液体、冻干粉
- 应用范围：
ICC=1:50-200 IF=1:50-200
- 浓度：
1mg/ml
- 保存条件：
-20 °C
- 规格：
100ul
| 英文名称 | Anti-C1QC/FITC |
| 中文名称 | FITC标记的补体C1qγ链多肽抗体 |
| 别 名 | C1Q C; C1qc; C1QC_HUMAN; C1QG; Complement C1q subcomponent subunit C; Complement component 1, q subcomponent, C chain; complement component 1, q subcomponent, gamma polypeptide; AI385742. |
| 规格价格 | 100ul/2980元 购买 大包装/询价 |
| 说 明 书 | 100ul |
| 研究领域 | 免疫学 神经生物学 细胞类型标志物 |
| 抗体来源 | Rabbit |
| 克隆类型 | Polyclonal |
| 交叉反应 | Human, Mouse, Rat, Dog, Horse, Rabbit, |
| 产品应用 | ICC=1:50-200 IF=1:50-200 not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 23kDa |
| 性 状 | Lyophilized or Liquid |
| 浓 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human C1QC |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 储 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存条件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| 产品介绍 | background: C1q, a subcomponent of the classical complement pathway, is composed of nine subunits that mediate classical complement activation and thereby play an important role in the immune response. Six of these subunits are disulfide-linked dimers of chains A and B, while three of these subunits, designated C1q-A through C1q-C, are disulfide-linked dimers of chain C. The presence of receptors for C1q on effector cells modulates its activity, which may be antibody-dependent or independent. Macrophages are the primary source of C1q, while anti-inflammatory drugs as well as cytokines differentially regulate expression of the mRNA, as well as the protein. However, its ability to modulate the interaction of platelets with collagen and immune complexes suggests C1q influences homeostasis as well as other immune activities, and perhaps thrombotic complications resulting from immune injury. Defects in C1q-A, C1q-B and C1q-C cause inactivation of the classical pathway, leading to a rare genetic disorder characterized by lupus-like symptoms. Function: C1q associates with the proenzymes C1r and C1s to yield C1, the first component of the serum complement system. The collagen-like regions of C1q interact with the Ca(2+)-dependent C1r(2)C1s(2) proenzyme complex, and efficient activation of C1 takes place on interaction of the globular heads of C1q with the Fc regions of IgG or IgM antibody present in immune complexes. Subunit: C1 is a calcium-dependent trimolecular complex of C1q, R and S in the molar ration of 1:2:2. C1q subcomponent is composed of nine subunits, six of which are disulfide-linked dimers of the A and B chains, and three of which are disulfide-linked dimers of the C chain. Subcellular Location: Secreted. Post-translational modifications: O-linked glycans consist of Glc-Gal disaccharides bound to the oxygen atom of post-translationally added hydroxyl groups. DISEASE: Defects in C1QC are a cause of complement component C1q deficiency (C1QD) [MIM:613652]. A rare defect resulting in C1 deficiency and impaired activation of the complement classical pathway. C1 deficiency generally leads to severe immune complex disease with features of systemic lupus erythematosus and glomerulonephritis. Similarity: Contains 1 C1q domain. Contains 1 collagen-like domain. Database links: Entrez Gene: 714 Human Entrez Gene: 12262 Mouse Entrez Gene: 362634 Rat Omim: 120575 Human SwissProt: P02747 Human SwissProt: Q02105 Mouse SwissProt: P31722 Rat Unigene: 467753 Human Unigene: 439732 Mouse Unigene: 2393 Rat Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相联在一起，同时C1r还是C1q和C1s的联桥。C1s是一种α2球蛋白，单链，可被C1r激活，医学教育|网搜集整理C1s具有酶样活性，在Mg2+存在时激活C4和C2。 2.C4 是一种β球蛋白，由3条多肽链组成（α，β，γ），分子量分别是95kD、78kD和33kD.C1s可将3条链中最大的α链裂解，释放出一较小的多肽C4a，余下的大部分结合在靶细胞上，进行补体的下一步活化程序。 3.C2 是一种β球蛋白，单链，是血清中含量最少的补体成分。激活的C2极不稳定，易衰变，形成补体系统中的一种自身调节
光抗体染色法 本法应用直接法或间接法的原理和步骤，可对活细胞在试管内进行染色，常用于 T 和 B 细胞、细胞培养物、瘤细胞抗原和受体等的检查和研究，阳性荧光主要在细胞膜上。FACS 即采用此法原理。 （五）双重染色法 在同一标本上有两个抗原需要同时显示（如 A 抗原和 B 抗原），A 抗原的抗体用 FITC 标记，B 抗原的抗体用罗达明标记，可采用以下染色方法： 1．一步法双染色 先将两种标记抗体按适当比例混合（A+B），按直接法进行染色。 2．二步法双染色 先用 RB200 标记的 B
小的如立克氏体、病毒颗粒等或浓度较低的抗原物质时甚为理想。 （四）膜抗原荧光抗体染色法 本法应用直接法或间接法的原理和步骤，可对活细胞在试管内进行染色，常用于T和B细胞、细胞培养物、瘤细胞抗原和受体等的检查和研究，阳性荧光主要在细胞膜上。FACS即采用此法原理。 （五）双重染色法 在同一标本上有两个抗原需要同时显示（如A抗原和B抗原），A抗原的抗体用FITC标记，B抗原的抗体用罗达明标记，可采用以下染色方法： 1．一步
技术资料暂无技术资料 索取技术资料
